Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis system

Several vaccine platforms have been developed to fight pathogenic threats, with Virus-Like Particles (VLPs) representing a very promising alternative to traditional platforms. VLPs trigger strong and lasting humoral and cellular immune responses with fewer safety concerns and higher stability than o...

Descripción completa

Detalles Bibliográficos
Autores principales: Armero-Gimenez, Jorge, Wilbers, Ruud, Schots, Arjen, Williams, Charles, Finnern, Ricarda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909599/
https://www.ncbi.nlm.nih.gov/pubmed/36776898
http://dx.doi.org/10.3389/fimmu.2023.1088852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909599/
https://www.ncbi.nlm.nih.gov/pubmed/36776898
http://dx.doi.org/10.3389/fimmu.2023.1088852

Ejemplares similares